These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29268400)

  • 41. A retrospective study of the relationship between the pathologic subtype and lymph node metastasis of lung adenocarcinomas of ≤3 cm diameter.
    Lin W; Huang M; Zhang Z; Chai T; Chen S; Gao L; Lin J; Kang M
    Medicine (Baltimore); 2020 Sep; 99(36):e21453. PubMed ID: 32898994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cryobiopsy as a reliable technique for the preoperative identification of micropapillary/solid components in early-stage lung adenocarcinoma.
    Suzuki M; Matsumoto Y; Imabayashi T; Teishikata T; Tsuchida T; Asamura H; Yatabe Y
    Lung Cancer; 2021 Dec; 162():147-153. PubMed ID: 34814012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multivariate Analysis Of The Diagnostic Yield Of Conventional Bronchoscopy In Peripheral Lung Adenocarcinoma.
    Gao W; Li C; Wang H; Han P; Nie Y
    Cancer Manag Res; 2019; 11():9883-9889. PubMed ID: 31819625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma: A Comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma.
    Lee HY; Lee SW; Lee KS; Jeong JY; Choi JY; Kwon OJ; Song SH; Kim EY; Kim J; Shim YM
    J Thorac Oncol; 2015 Dec; 10(12):1785-94. PubMed ID: 26473646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significance of histologic subtype size as a prognostic indicator in stage IA lung adenocarcinoma.
    Jeon HW; Kim YD; Sim SB
    J Thorac Dis; 2023 Oct; 15(10):5405-5413. PubMed ID: 37969277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation Study of
    Yang B; Ji H; Ge Y; Chen S; Zhu H; Lu G
    Front Oncol; 2019; 9():908. PubMed ID: 31620365
    [No Abstract]   [Full Text] [Related]  

  • 47. Solid histological component of adenocarcinoma might play an important role in PD-L1 expression of lung adenocarcinoma.
    Miyazawa T; Morikawa K; Otsubo K; Sakai H; Kimura H; Chosokabe M; Furuya N; Marushima H; Kojima K; Mineshita M; Koike J; Saji H
    Thorac Cancer; 2022 Jan; 13(1):24-30. PubMed ID: 34811933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Solid predominant histology predicts EGFR tyrosine kinase inhibitor response in patients with EGFR mutation-positive lung adenocarcinoma.
    Yoshida T; Ishii G; Goto K; Yoh K; Niho S; Umemura S; Matsumoto S; Ohmatsu H; Nagai K; Ohe Y; Ochiai A
    J Cancer Res Clin Oncol; 2013 Oct; 139(10):1691-700. PubMed ID: 23974272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor-size-based morphological features of metastatic lymph node tumors from primary lung adenocarcinoma.
    Yamada E; Ishii G; Aramaki N; Aokage K; Hishida T; Yoshida J; Kojima M; Nagai K; Ochiai A
    Pathol Int; 2014 Dec; 64(12):591-600. PubMed ID: 25354789
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma.
    Gao S; Stein S; Petre EN; Shady W; Durack JC; Ridge C; Adusumilli P; Rekhtman N; Solomon SB; Ziv E
    Cardiovasc Intervent Radiol; 2018 Feb; 41(2):253-259. PubMed ID: 28770314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Both the presence of a micropapillary component and the micropapillary predominant subtype predict poor prognosis after lung adenocarcinoma resection: a meta-analysis.
    Wang W; Hu Z; Zhao J; Huang Y; Rao S; Yang J; Xiao S; Cao R; Ye L
    J Cardiothorac Surg; 2020 Jun; 15(1):154. PubMed ID: 32600473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genomics Analysis and Nomogram Risk Prediction of Occult Lymph Node Metastasis in Non-Predominant Micropapillary Component of Lung Adenocarcinoma Measuring ≤ 3 cm.
    Wang K; Xue M; Qiu J; Liu L; Wang Y; Li R; Qu C; Yue W; Tian H
    Front Oncol; 2022; 12():945997. PubMed ID: 35912197
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
    Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
    J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modified histologic classification as a prognostic factor in pulmonary adenocarcinoma.
    Hwang I; Park KU; Kwon KY
    Int J Surg Pathol; 2014 May; 22(3):212-20. PubMed ID: 24599899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Volume and Mass Doubling Time of Lung Adenocarcinoma according to WHO Histologic Classification.
    Hong JH; Park S; Kim H; Goo JM; Park IK; Kang CH; Kim YT; Yoon SH
    Korean J Radiol; 2021 Mar; 22(3):464-475. PubMed ID: 33169551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography.
    Nakamura H; Saji H; Shinmyo T; Tagaya R; Kurimoto N; Koizumi H; Takagi M
    Lung Cancer; 2015 Jan; 87(1):28-33. PubMed ID: 25481488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship of Lymph Node Micrometastasis and Micropapillary Component and Their Joint Influence on Prognosis of Patients With Stage I Lung Adenocarcinoma.
    Dai C; Xie H; Kadeer X; Su H; Xie D; Ren Y; She Y; Zhu E; Fan Z; Chen T; Qin L; Zheng H; Zhang L; Jiang G; Wu C; Chen C
    Am J Surg Pathol; 2017 Sep; 41(9):1212-1220. PubMed ID: 28692600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
    Luo J; Huang Q; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Wang Y; Zheng J; Wu H; Xia W; Chen H
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):2031-40. PubMed ID: 27379889
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma.
    Caso R; Sanchez-Vega F; Tan KS; Mastrogiacomo B; Zhou J; Jones GD; Nguyen B; Schultz N; Connolly JG; Brandt WS; Bott MJ; Rocco G; Molena D; Isbell JM; Liu Y; Mayo MW; Adusumilli PS; Travis WD; Jones DR
    J Thorac Oncol; 2020 Dec; 15(12):1844-1856. PubMed ID: 32791233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Factors in Completely Resected Node-Negative Lung Adenocarcinoma of 3 cm or Smaller.
    Hung JJ; Yeh YC; Wu YC; Chou TY; Hsu WH
    J Thorac Oncol; 2017 Dec; 12(12):1824-1833. PubMed ID: 28739441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.